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148 Poster Session IIthe development and implementation of successful strategies to
guide the care of patients with steroid induced psychosis.
Successful nursing care plans for inpatients with acute psychosis
must be multi-disciplinary, prioritized to both provide for the pa-
tient’s safety and designed to ensure compliance with prescribed
medications to avoid GVHD exacerbation and infection. When
possible, the team should enlist the support of family members,
who can provide invaluable insight into the patient’s history and
a more thorough assessment of home resources. Timely recognition
of the signs and symptoms of psychosis, coupled with early interven-
tion, is vital to ensuring successful management and resolution.
Maintaining a consistent caregiver team, employing a 24 hour sitter,
tracking sleep/wake patterns, and encouraging short term/goal di-
rected activities have proven successful. Nurses play a key role in
implementing each of these measures.
A case study will be presented to illustrate nursing interventions
used to manage a patient with steroid-induced psychosis at our
comprehensive cancer center.410
TOTAL GLUCOSE CONTROL (TGC): A GLUCOSE CONTROL PROJECT FOR
STAFF NURSES
Latchford, T.M., Knoepfel, R. Stanford Hospital and Clinics, Stanford,
CA.
Problem: Both the American Diabetes Association and the
American College of Endocrinology have released position state-
ments and standards of medical care regarding glucose control.
The goal is to maintain blood glucose levels of less than 180 mg/
dL in the non intensive care unit (ICU) patient and less than 110
mg/dL at all times in the ICU patient. On the Blood and Marrow
Transplant inpatient unit in 2005 and 2006 the average fingerstick
blood glucose was 209 mg/dL and 200 mg/dL, respectively, well
above the averages of 154 mg/dL and 148 mg/dL of all other inpa-
tients. These high glucoses reflected a lack of compliance with best
practices. The combination of challenges unique to the BMT pop-
ulation include; pain, medical stress, total parental nutrition, and
regular use of glucocorticoids and other immunosuppressants. De-
spite these unique challenges our inpatient unit implemented a total
glucose control (TGC) project in an effort to improve blood glucose
management. Goals: The primary goal of our project was to lower
the inpatient unit’s blood glucose levels by 20%, to an average of
\180 mg/dL. In order to accomplish this, we increased the use of
intravenous insulin infusions and basal-bolus insulin regimens. To
prevent episodes of hyopoglycemia intensive staff education was
provided. Patient education regarding hypoglycemia and blood glu-
cose management was instituted. Implementation: A series of in-
services were developed for BMT physicians and nursing staff.
Pre-project and post-project audits were performed to evaluate
blood glucose levels, length of time until initiation of insulin ther-
apy, number of hypoglycemic episodes, and documentation of pa-
tient education. Results: The TGC project was successful as the
blood glucose average remains less than 180 mg/dL. Conclusion:
To better manage our patients, more education and experience is
needed with the use of the insulin infusion and basal bolus manage-
ment. The insulin infusion is complicated and requires vigilent
management.
The development of guidelines for blood glucose testing and in-
sulin therapy is needed to meet the unique challenges posed by the
BMT patient.
The next step in the TGC project is to implement these standards
in the outpatient setting.411
RITUXIMAB MONITORING IN HEMATOPOIETIC STEM CELL TRANS-
PLANT: HOW MUCH IS NECESSARY?
Blackburn, R.K., Wood, G., Mick, J.M., Munsell, M.S., Neumann, J.,
Johnston, P. University of Texas MD Anderson Cancer Center, Houston,
TX.Background:Rituximab, an uncongugated monoclonal antibody
that reacts with the CD20 molecule present on most malignant B-
cells, is standard treatment for patients with lymphoma. Most ritux-
imab infusions are well tolerated with a mild infusion related symp-
tom complex (fever, chills/rigors) usually occurring within 1 hour
after initiation. Severe infusion related reactions (IRR), such as
bronchospasm and hypotension, occur infrequently; most often
within 2 hours after initiating the first dose. Reactions are caused
by cytokine release associated with high numbers of circulating tu-
mor cells. Incidence of IRRs decreases markedly with subsequent
infusions. At a university based comprehensive cancer center, con-
trolled trials using rituximab for treatment of NHL are underway
in hematopoietic stem cell transplant patients to determine optimal
dosing and scheduling. Patients participating in these trials are
heavily pretreated with rituximab, and are in partial or complete re-
mission before admission for transplant. Based on phase I and II tri-
als, frequent vital sign (VS) monitoring and concurrent
administration of normal saline are recommended. Current organi-
zational clinical practice standards require between 10–16 sets of VS
over 5–6 hours for average rituximab infusions; interfering with pa-
tient comfort and requiring significant nursing time. Purpose: To
determine the frequency and risk of IRRs in patients admitted for
transplant and an optimal vital sign monitoring schedule. Method:
A nurse initiated, IRB-approved, retrospective review of 200 medi-
cal records was conducted. Data analysis is in progress to determine
IRR frequency, identify patients at high risk for reactions, and de-
termine an appropriate VS schedule. Results: Study findings will
be reported.412
WHOSE WHO? A BROWN BAG LUNCH PROGRAM FOR THE STANFORD
BLOOD AND MARROW TRANSPLANT INPATIENT STAFF
Latchford, T.M. Stanford Hospital and Clinics, Stanford, CA.
Stanford University’s Blood and Marrow Transplant (BMT) Pro-
gram performs over 200 transplants a year. Over 150 employees
with diverse backgrounds and responsibilities perform varied func-
tions to faciliate care of BMT recipients and families. The more
than 150 employees are scattered throughout at least 10 different
areas within the university, hospital and clinics. The BMT Program
staff include: physicians, nurses, advance practice nurses, physician
assistants, nurse coordinators, nursing assistants, unit secretaries,
houskeepers, social workers, physical therapists, dieticians, pharma-
cists, financial coordinators, unrelated donor search coordinator,
administrative staff, stem cell transplant lab technicians, and basic
scientists.
In an effort to help the nurse get to know the diverse role of other
BMT staff within the BMT program, we initiated a brown bag
lunch ‘‘Whose Who Program’’. The Whose Who program asks
a representative from a given area to bring their lunch, sit, and
talk with the nurses over lunch. The goals of the Whose Who pro-
gram are: 1) to share expertise, 2) to allow staff to get to know others
in the BMT program, 3) to develop an understanding of the many
different roles required to care for BMT patients and families. Eat-
ing lunch, getting to know one another, and discussing how each
area contributes to the care of patients in a casual environment
has helped to build a more cohesive team among the many players
that work in our program.413
PRE-STEM CELL TRANSPLANT EDUCATION EFFECT ON PATIENT ANXI-
ETY LEVELS
Scherer, T.M. Christiana Care Health System, Newark, DE.
Stem cell transplantation is a highly technological treatment uti-
lized primarily for hematological malignancies but also used as
treatment for selected solid tumor malignancies as well as benign
disease processes. The concept of impending stem cell transplanta-
tion alone is frightening. The distress caused by the diagnosis and
impending complicated treatment can have a negative impact on
